Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatoid Arthritis: Time Is of the Essence

Sue Pondrom  |  Issue: June 2008  |  June 1, 2008

Dr. Firestein agrees. “The primary care doctors have to be trained to know exactly what to look for,” he says. According to Dr. Paget, “because medical school and house staff training in the recognition, diagnosis, and treatment of such disorders is so poor, is it a surprise that well-intentioned physicians on the front line either miss or mistreat these diagnoses or patients altogether because they don’t even know what they don’t know?”

“It’s, in many ways, a grassroots effort with medical schools,” Dr. Paget says, urging rheumatologists to get involved. “The schools have ‘x’ amount of time and resources to do a huge amount of education. They basically cram it in. As a result, a specialty like rheumatology suffers.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Cush, who runs an EAC and frequently lectures, says that, while education is certainly needed, most PCPs want to know who and when to refer. Therefore, with his PCPs, he promotes the “Referral Rules” advocated by Paul Emery, MD, professor of rheumatology at the University of Leeds, U.K., that require six weeks of joint symptoms and one of the following symptoms: three or more swollen joints a positive metacarpophalangeal (MCP) or metatarsophalangeal (MTP) squeeze test, morning stiffness for more than 45 minutes, or abnormal labs (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], rheumatoid factor [RF], or classical complement pathway [CCP]).

Dr. Cush believes that “the guy in the trenches, the primary care internist or physician, has no intention of going to a lecture designed to educate them on early RA. They’ve got too many things to deal with already. Thus, we have to create rules that can facilitate patient referral.” To get the word out about the rules, Dr. Cush suggests a $5–10-million national advertising campaign aimed at both PCPs and the general public. He suggests it might be funded by stakeholders (e.g., pharmaceutical companies, foundations, societies, etc.).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“My idea is to make Tuesday ‘Early Arthritis Day,’ ” he says. “Your rheumatologist will see patients every Tuesday and all the PCP needs to do is fill out a prescription pad for the walk-in visit.”

A new initiative is starting at Dr. Cush’s EAC. He is working with the hospital’s public relations department to reach all local primary care doctors in the community, providing referral rules and indicating that nine doctors in the EAC will see patients within two weeks of referral. In Birmingham, Dr. Moreland’s EAC was established by sending out letters to all PCPs in Alabama, saying that his group will try to see all patients in a timely manner. In smaller communities, such as Santa Barbara, Calif., it’s easier for a dedicated rheumatologist to spread the message to area primary care physicians. Timothy Spiegel, MD, MPH, a rheumatologist in Santa Barbara, Calif., who has been in private practice for the past 20 years, knows all the local PCPs and says he has trained many of them to recognize early RA. He makes sure to see referred patients within a week.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsRheumatoid Arthritis Tagged with:clinicDiagnosisDiagnostic CriteriaRheumatoid arthritisTreatment

Related Articles

    Stop the Rheumatoid Arthritis (RA) Cascade Early

    May 1, 2008

    Early arthritis clinics pioneered diagnosis and treatment to prevent disease progression

    Key Studies Highlighted: 2 Industry Veterans Discuss Their Favorite Annual Meeting Abstracts

    March 19, 2020

    ATLANTA—With more than 3,000 abstracts from 103 countries presented at the 2019 ACR/ARP Annual Meeting in November, it was impossible for attendees to view them all. However, two ACR/ARP veterans—Arthur Kavanaugh, MD, from the University of California, San Diego, and John Cush, MD, from UT Southwestern Medical School, Dallas—chose to tackle the nearly impossible task and…

    Tips to Improve Communication with Colleagues & Patients

    October 31, 2019

    Crafting clear and captivating messaging for patients and colleagues isn’t always easy. Here are some tips to improve your approach…

    The Latest Autoinflammatory Discoveries & Tips

    March 17, 2018

    SAN DIEGO—Since the identification of the autoinflammatory disease, familial Mediter­ranean fever (FMF), researchers have identified an alphabet soup of other auto­inflammatory diseases with genetic underpinnings, from PAPA (pyogenic arthritis with pyoderma gangrenosum and acne) to NIAID (NLRP1-associated autoinflammation with arthritis and dyskeratosis) to TRAPS (TNF receptor-associated periodic syndrome). The torrent of discoveries, brought about largely…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences